Rosine F Bishara

Ms. Rosine F Bishara

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Children
Verified
Journal Article
Open access
PDF file
GRGiulia Res
Giulia Res
RBRosine F Bishara
Rosine F Bishara
PCPaige Church
Paige Church
RRRena Rosenthal
Rena Rosenthal
RBRita Maria Bishara
Rita Maria Bishara
BRBanihani Rudaina
Banihani Rudaina
Background: This study aimed to assess the impact of a nutrition-care bundle on growth and neurodevelopmental outcomes of micro-preterm infants born in a level III neonatal intensive care unit (NICU) by two years corrected age. Methods: A nutrition-care bundle emphasizing the prompt initiation of parenteral nutrition at birth, initiation of enteral feeds within 6 h after birth, and early addition of human milk fortifiers was implemented in 2015 for infants born < 26 weeks gestation. This before-and-after study evaluated growth and neurodevelopmental outcomes in infants born between 2012–2013 (before-nutrition-bundle, BNB) and 2016–2017 (after-nutrition-bundle, ANB). Results: A total of 145 infants were included in the study. Infants in the ANB group (n = 73) were smaller (birthweight and gestational age), and there were more male infants and multiples included compared to the BNB group (n = 72). Enteral feeds and fortifiers started earlier in the ANB group. Growth velocity and weight z-score changes were similar in both groups during NICU stay and post-discharge. Systemic steroid use, but not cohort, was linked to lower Bayley scores across all domains. Conclusions: Implementing a nutrition-care bundle was not consistently associated with improved weight gain and neurodevelopmental outcomes in the micro-preterm infant population, possibly due to ongoing high-quality nutritional care by the clinical team.

5 October 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
MBMegan Beggs
Megan Beggs
DPDubraiicka Pichardo
Dubraiicka Pichardo
ACAnnette Chrzaniecki
Annette Chrzaniecki
KKKirsten Kotsopoulos
Kirsten Kotsopoulos
RBRosine F Bishara
Rosine F Bishara
DODeborah L O’cOnnor
Deborah L O’cOnnor
Introduction To meet the elevated nutritional requirements of very low birthweight (<1500 g, VLBW) infants during hospitalisation, many neonatal units routinely add a fixed dose of multinutrient fortifier to human milk. Individualised approaches that either tailor macronutrient additions to routine analysis of milk composition (target fortification) or an infant’s metabolic response to nutrition (blood urea nitrogen (BUN) adjustable fortification) show short-term improvement in growth, but important outcomes such as longer-term neurodevelopment and major in-hospital morbidity have not been systematically assessed. The aim of our study is to determine whether target or BUN adjustable fortification of human milk, compared with standard fortification, during hospitalisation improves cognitive (primary), language and motor development of VLBW infants at 18–24 months corrected age (CA). Secondary outcomes include growth, body composition, mortality and serious morbidity. Methods and analysis This is a three-arm, pragmatic, multicentre, double-blind, randomised clinical trial of 615 human milk–fed infants born either (1) ≤1250 g or (2) <30 weeks and <1500 g. Once enteral feeds reach 100 mL/kg/day, and until 36 weeks corrected gestational age (CGA), infants are fed according to one of three fortification protocols: (1) standard fortification, in which a fixed dose of nutrients is added to human milk; (2) target fortification, in which values from twice weekly direct analysis of mother’s milk and each batch of donor milk are used to provide 4 and 4.8 g/kg/day true protein and fat, respectively; and (3) BUN adjustable fortification, in which weekly BUN values are used to adjust protein fortification of milk. Neurodevelopment is assessed using the Bayley-IV scale at 18–24 months CA. Growth, morbidities and nutrient intakes are recorded daily during hospitalisation, and skinfolds are measured at 36 weeks CGA and at 4 months CA. At 4 months CA, body composition is determined by air displacement plethysmography on a subset of infants. Ethics and dissemination Ethical approval was obtained from Clinical Trials Ontario (CTO) and local research ethics boards that are not CTO members. Study findings will be disseminated to clinicians at seminars and conferences and in peer-reviewed publications. Trial registration number NCT05308134.

1 April 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GRGiulia Res
Giulia Res
RBRosine F Bishara
Rosine F Bishara
PCPaige Church
Paige Church
RRRena Rosenthal
Rena Rosenthal
RBRita Maria Bishara
Rita Maria Bishara
BRBanihani Rudaina
Banihani Rudaina
Background: This study aimed to assess the impact of a nutrition-care bundle on growth and neurodevelopmental outcomes of micro-preterm infants born in a level III neonatal intensive care unit (NICU) by two years corrected age. Methods: A nutrition-care bundle emphasizing the prompt initiation of parenteral nutrition at birth, initiation of enteral feeds within 6 hours after birth, and early addition of human milk fortifiers was implemented in 2015 for infants born <26 weeks gestation. This before-and-after study evaluated growth and neurodevelopmental outcomes in infants born between 2012-2013 (before-nutrition-bundle BNB) and 2016-2017 (after-nutrition-bundle ANB). Results: A total of 145 infants were included in the study. Infants in the ANB group (n=73) were smaller (birthweight and gestational age), and there were more male infants and multiples included compared to the BNB group (n=72). Enteral feeds and fortifiers started earlier in the ANB group. Growth velocity and weight-z-score changes were similar in both groups during NICU stay and post-discharge. Systemic steroid use, but not cohort, was linked to lower Bayley scores across all domains. Conclusions: Implementing a nutrition-care bundle was not consistently associated with improved weight-gain and neurodevelopmental outcomes in the micro-preterm infant population, likely due to ongoing high-quality nutritional care by the clinical team.